Bold Ventures Inc. (TSXV: BOL,OTC:BVLDF) (the ‘Company’ or ‘Bold’) is pleased to announce that it has signed an agreement…
Investing
InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer’s Disease Candidate INM-901
Data will support design and planning of first in human clinical trials Preparing for pre-IND meeting with the FDA…